article thumbnail

The Future of Pharma Production, Manufacturing and Packaging

Drug Discovery Today

Through a series of exclusive interviews and a survey of industry insiders, Connect in Pharma names the top pharmaceutical and manufacturing-related trends of 2023

article thumbnail

Indian pharma manufacturing: rising investment in Andhra Pradesh

Pharmaceutical Technology

Indian pharma manufacturing continues to be the backbone of drug supplies worldwide, and GlobalData analysis suggests US overreliance on the country for generic drug supply. Pharma manufacturing facilities in Andhra Pradesh and Telangana accounted for 22.5% © GlobalData. © GlobalData.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Bright future of Pharma Manufacturing Sector in India

Creogenic Pharma

250+ Products. Bright future of Pharma Manufacturing Sector in India: The majority of us understand that India was doing very great in the pharma industry for the last couple of decades. The pharma industry of India is increasing at an outstanding speed. Bright Future Of Pharma Manufacturing Sector In India.

article thumbnail

Benefits of Third Party Manufacturing of Pharmaceuticals

Fossil Remedies

ADVANTAGES OF THIRD PARTY MANUFACTURING IN PHARMA INDUSTRY. Amongst various business models used by people in the pharma manufacturing niche, third-party manufacturing is popular. Cost-effective production. The third-party pharma manufacturing model makes the whole process cost-effective.

article thumbnail

Leading freeze-drying systems suppliers for the pharmaceutical industry

Pharmaceutical Technology

The list includes companies that offer freeze-drying products including, but not limited to, laboratory freeze dryers, industrial freeze dryers, nested vial systems, dry evaporators, concentrators, cold traps, glove boxes, freeze drying trays and shelves, glassware washers, water purification systems, and fume hoods.

article thumbnail

Innate Pharma and Takeda sign licence deal to develop ADCs for coeliac disease

Pharmaceutical Technology

Innate Pharma has signed an exclusive licence agreement with Takeda to enable research and development of antibody drug conjugates (ADCs) against an undisclosed target, primarily focusing on coeliac disease. In addition, Innate will receive royalties on possible net sales of any commercial product to be developed under the licence.

article thumbnail

Magazine: ‘Right shoring’ API production in Europe

Pharmaceutical Technology

In the last few years, there have been growing calls to onshore the manufacturing of certain pharma products, including active pharmaceutical ingredients (API), to ensure a smooth supply and to minimise shortages in the European Union (EU).